People living with HIV who are admitted to the hospital with COVID-19 are no more likely to die than those without HIV, an analysis conducted in New York City shows. This is despite the fact that comorbidities associated with worse COVID-19 outcomes were more common in the HIV group.
“We don’t see any signs that people with HIV should take extra precautions” to protect themselves from COVID-19, said Keith Sigel, MD, associate professor of medicine and infectious diseases at the Icahn School of Medicine at Mount Sinai in New York City, and the lead researcher on the study, published online June 28 in Clinical Infectious Diseases.
“We still don’t have a great explanation for why we’re seeing what we’re seeing,” he added. “But we’re glad we’re seeing it.”
The findings have changed how Sigel talks to his patients with HIV about protecting themselves from COVID-19. Some patients have so curtailed their behavior for fear of acquiring COVID-19 that they aren’t buying groceries or attending needed medical appointments. With these data, Sigel said he’s comfortable telling his patients, “COVID-19 is bad all by itself, but you don’t need to go crazy. Wear a mask, practice appropriate social distancing and hygiene, but your risk doesn’t appear to be greater.”
GSA Executive Committee member Prof. Flavia Machado was interviewed by the JAMA Network on “Coronavirus in Brazil – Report From The Front Lines”.
The interview provides a very insightful overview on how Brazil is tackling the pandemic, the efficiency of treatments, and solutions adopted by hospitals to respond to the crisis. Interestingly, Prof. Machado confirmed that in most cases people are dying from refractory septic shock rather than refractory hypoxemia.
Besides, she noted that the usual differences between high (HICs) – and low- and middle-income countries (LMICs), where 85% of sepsis cases occur, are not so visible with COVID-19, in fact, the most affected countries are HICs.
Prof. Machado is chair of the intensive care session of Anesthesiology, Pain and Intensive Care Department at the Federal University of São Paulo, Brazil, and CEO of the Latin America Sepsis Institute (LASI).